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Abstract
Aim SpeciWc factors responsible for interindividual vari-
ability should be identiWed and their contribution quantiWed
to improve the usefulness of biological monitoring. Among
others, age is an easily identiWable determinant, which
could play an important impact on biological variability.
Materials and methods A compartmental toxicokinetic
model developed in previous studies for a series of metallic
and organic compounds was applied to the description of
age diVerences. Young male physiological and metabolic
parameters, based on Reference Man information, were
taken from preceding studies and were modiWed to take into
account age based on available information about age
diVerences.
Results Numerical simulation using the kinetic model
with the modiWed parameters indicates in some cases
important diVerences due to age. The expected changes are
mostly of the order of 10–20%, but diVerences up to 50%
were observed in some cases.
Conclusion These diVerences appear to depend on the
chemical and on the biological entity considered. Further
work should be done to improve our estimates of these
parameters, by considering for example uncertainty and
variability in these parameters.
Keywords Age · Toxicokinetic · Modeling · 
Biological indicators
Introduction
Biological monitoring is a method widely used by occupa-
tional physicians to estimate chemical exposure. However,
it is more and more often recognized that a large variability
is associated with biological monitoring, making interpreta-
tion less eYcient than foreseen (Truchon et al. 2006).
Toxicokinetic (TK) behavior of chemicals in the body
determines biological levels and thus biological indicator
results. It is usually described as four processes: absorption,
distribution, metabolism and elimination. Biological vari-
ability comes from changes in these four processes.
In a recent review, Truchon et al. (2004) indicate that the
question of the inXuence of age on industrial chemical tox-
icokinetics has received little attention. They recommend
that this aspect should be further studied, notably by TK
modeling, to better understand its contribution to biological
variability. A few authors have started to describe, using
various modeling tools, the contribution of age to biologi-
cal variability. Some authors have described diVerences
between children and adults (Kreuzer et al. 1997; O’Flah-
erty 1998; Hattis et al. 2003) and others have also taken in
account the elderly (Jeandel et al. 1992; Clewell et al. 2002,
2004). Hattis et al. (2003) drew on individual data for phar-
macokinetic and anthropometric parameters to help deWne
distributions that will be helpful for population distribution
modeling of pharmacokinetic diVerences between children
of various ages and adults. Clewell et al. (2004) presented
an initial attempt to provide a predictive pharmacokinetic
framework to evaluate the potential impact of age- and gen-
der-speciWc diVerences on risk from chemical exposure.
The validation of these chemical-speciWc model predictions
has been made with only young adult data.
It is presently still diYcult to understand quantitatively
the variability due to age associated with biological
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of contributing factors, as shown in a framework for age
diVerences by Geller and Zenick (2005), their relative
importance is unknown for diVerent chemicals of occupa-
tional interest. It is therefore presently unfeasible to use
such information to interpret biological variability and
make safer quantitative decisions when using biological
monitoring of exposure.
In preceding studies, Truchon et al. (2003) have devel-
oped TK tools to describe the inXuence of speciWc factors
on biological levels, such as body build, physical workload,
metabolic and excretion functions (Pierrehumbert et al.
2002; Truchon et al. 2006) but not age. One of these tools,
namely a simple TK model, was applied in the present
study to better understand the inXuence of age on biological
exposure indicators. The report in question represents a ten-
tative quantitative estimation of the eVect of age on biolog-
ical levels of several industrial chemicals and their
metabolites. It is then applied to speciWc biological moni-
toring reference values.
Methods
Compartmental toxicokinetic model
A compartmental TK model developed in previous studies
(Pierrehumbert et al. 2002) was applied to the description
of age diVerences. The TK model (see Fig. 1, taken from
Pierrehumbert et al. 2002) includes physiological parame-
ters deWning volumes and Xows to be able to mimic age
changes. It was adapted for each chemical according to
available data and TK information.
The route of absorption by inhalation is represented in
the model. In fact most of BEIs are based on a direct corre-
lation with the TLVs, which indicate the potential “inhala-
tion” exposure of a worker. Skin exposure is not included
in the models. The chemical is distributed between the cen-
tral compartment and the peripheral one, or storage com-
partment. These compartments can be illustrated by
diVerent tissues, depending on the chemical. The distribu-
tion can be either Xow or diVusion limited and includes the
permeability and aYnity of the tissue for the chemical. The
metabolism can give one or more metabolites, and can
occur by serial or parallel metabolism. Elimination is repre-
sented by excretion in expired air, feces and urine or by
metabolism. Information on the peripheral compartment
when it exits can be found in Table 2. The central compart-
ment is then composed of the resting tissues. The model is
completely described by Pierrehumbert et al. (2002). The
TK model was implemented in the simulation software
ITHINK ANALYST (version 7.02 for Windows, High Per-
formance System Inc., Hanover, NH, USA).
Physiological and metabolic parameters
Young male physiological and metabolic parameters were
taken from preceding studies and are based on Reference
Man information (Tardif et al. 2002). These parameters,
used to estimate speciWc data required for each chemical,
were modiWed to take into account age based on known
information about age diVerences. A 65-year-old man has
been chosen, based on the legal retirement age in Switzer-
land, to model diVerences due to age. Furthermore, the
present simulations do not take into account the apparition
of various diseases with age and the increased use of medi-
cations. The main parameters required by the model struc-
ture are body weight, cardiac output, blood Xows and
volumes of the relevant tissues, renal clearances and meta-
bolic constants. The detailed list of the parameters consid-
ered is presented in Table 1.
Changes in physiological and metabolic parameters
Clewell et al. (2004) developed separate sets of growth-
and age-related equations. These relations give an increase
in bodyweight of 5.5% from 25 to 65 years.
There is controversy about the eVect of age on cardiac
output. It has been described to decline with age (Birnbaum
1991). Clewell et al. (2004) have developed an age-related
equation for cardiac output with data obtained from
Åstrand (1983) and showed a diVerence of about 10%
between the ages of 25 and 65 years. According to Tonner
et al. (2003), cardiac output decreases in an almost linear
fashion after the third decade of life, with a rate of about
1% per year in healthy individuals without prevalent car-
diac disease. This would be a diVerence of 30% between
the ages of 25 and 60 years. Fagiolino et al. (2006) indicate
that cardiac output diminishes throughout life, changing 1%Fig. 1 Schematic diagram of the toxicokinetic model123
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RodeheVer et al. (1984) demonstrate that there is no signiW-
cant decline in cardiac output at rest or during exercise in
healthy adults between the ages of 25 and 79 years. How-
ever, aging does alter the mechanism by which cardiac out-
put is maintained during exercise. Ribera-Casado (1999)
insists on the fact that in healthy elderly people, cardiac
output remains practically unchanged. Ferrari et al. (2003),
in a review about age and cardiovascular system, show that
cardiac output is preserved with age in the resting heart.
Based on these last references, cardiac output was consid-
ered here to remain unchanged with age for modeling
purposes.
Concerning body composition, there is a progressive
reduction in total body water and lean body mass, resulting
in a relative increase in body fat with age (Mangoni and
Jackson 2003). According to the ICRP (1975), the body fat
fraction of weight is about 11% for a 20-year-old man and
about 30% for a 70-year-old man. Several authors (Kyle
et al. 2001; Turnheim 2003; McLean and Le Couteur 2004)
mention that body fat increases by 20–40% and body water
decreases by 10–15% in old age. For the TK models, body
fat was considered to increase by 30% with age.
Clewell et al. (2004) analyzed data on brain and liver
weights as fractions of body weight for a Japanese popula-
tion. A calculation shows that the variation of liver volume
between the ages of 25 and 65 years is about 6%. Le Cou-
teur and McLean (1998) show that in general the reduction
of liver size with age is noted to be of the order of 25–35%.
After the report of the Task Group on Reference Man, liver
weight decreases particularly after an age of 70 years (Sny-
der et al. 1975). Chouker et al. (2004) have developed for-
mulas for the estimation of liver size upon data obtained on
liver weight from 728 legal autopsies analyzed with respect
to gender, age, body height, body weight, body mass index
and body surface area. From these data, the decrease in
liver size is about 8% between the ages of 25 and 65 years.
Finally, on basis of the formulas developed by Chouker
et al., a decrease of 8% has been retained for the TK model
simulations.
Several authors describe the decrease of the kidney
weight with age (Löf and Johanson 1998; Mühlberg and
Platt 1999; McLean and Le Couteur 2004; Geller and
Zenick 2005). The aging kidney shows a decrease in weight
of about 20–30%, especially in the 70s and 80s (Silva
2005). Epstein (1996) mentions a decline in male kidney
weight of 19%. For the TK models, a variation of 20% has
been Wxed.
Renal blood Xow decreases after the fourth decade by
about 10% each decade (Silva 2005) and this is not related
to cardiac output. A variation of 25% was thus included in
the TK models.
Age-related declines in hepatic blood Xow ranging
between <0.5 and 1.5% per year have been reported
(Schmucker 2001). This would produce a greater than 40%
decline between 25 and 90 years of age. According to
Table 1 Parameters used in the TK models
Age-related changes in physiological and metabolic parameters (age 65 years compared to age 25 years)
a The reference values are adjusted to the body surface using a formula where body weight is related to the body surface when raised at a given
power
b Truchon et al. 2003
c Values are chemical-dependent
Parameter Unita Valueb
Age 25 years
Rest 50 W
Variation (%) Reference for the variation
BW Body weight kg 70 +5.50 Clewell et al. 2004
Qc Cardiac output l/h/kg0.7 18.0 30.8 = Ribera-Casado 1999; Ferrari et al. 2003 
FVTBW Total body water (TBW) l/kg 0.62 ¡15 McLean and Le Couteur 2004
FVfat Fat fraction of body weight l/kg 0.19 +30 Kyle et al. 2001
FVliver Liver fraction of body weight l/kg 0.026 ¡8 Chouker et al. 2004
FVkidney Kidney fraction of body weight l/kg 0.004 ¡20 Epstein 1996; Silva 2005 
BFfat Fat fraction of cardiac output - 0.05 0.06 +30 Clewell et al. 2004
BFliver Liver fraction of cardiac output - 0.26 0.16 ¡20 Zoli et al. 1999
BFkidney Kidney fraction of cardiac output - 0.11 0.20 ¡25 Silva 2005
kur Urinary excretion rate l/h/kg0.82 1.848 ¡30 Epstein 1996; Clewell et al. 2004
kcr Creatinine excretion rate mol/h/kg0.9 12.06 ¡30 Epstein 1996; Clewell et al. 2004
RC Renal clearance l/h/kg¡0.3 –c ¡30 Epstein 1996; Clewell et al. 2004
KM Michaelis–Menten constant mol/l –c ¡8 Clewell et al. 2004
VM Michaelis–Menten maximal rate mol/h/kg0.75 –c ¡8 Clewell et al. 2004123
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40 years to those over 65 years, there is a decrease of 35%
in hepatic blood Xow. Zoli et al. (1999) found a decrease of
about 20% between subjects under 45 years and subjects
between 61 and 75 years. Based on this information, a 20%
reduction in hepatic blood Xow was chosen for the TK
models.
Clewell et al. (2004) calculate the age-speciWc metabo-
lism rates by using the adult metabolism rate, the adult liver
volume, the age-speciWc liver volume and the appropriate
linearly interpolated fractional activity (gives enzyme
activity as a fraction of the adult level). DiVerent enzyme
systems have been taken in account: CYP2E1, CYP1A2,
CYP2C, ADH. As these fractional activities do not change
between the young adult and the old adult, the changes of
the metabolism rates will depend on the liver volume. For
our TK models, we decided to use the same variation as for
the liver volume, which is about 8%.
The parameter, which often determines renal function, is
the glomerular Wltration rate. Clewell et al. (2004) describe
the age-related diVerences for urinary clearance parameters
by a set of equations based on data on glomerular Wltration
rates. The variation is about 25% between a person of
25 years and one of 65 years. According to Epstein (1996)
and Mühlberg and Platt (1999), those variations for the
same ages can be about 30%, after a widely used formula
developed by Cockcroft and Gault (1976) for estimating the
creatinine clearance. Berg (2006) shows similar diVerences
by using other methods (clearances of inulin and para-ami-
nohippurate) for evaluating the glomerular Wltration rate.
The skeleton bone tissues also show some decrease with
age. The loss of bone has been estimated to be about 5–
10% per decade, beginning at about 30 years of age (Sny-
der et al. 1975). A value has been Wxed at 20% for the sim-
ulation of a young and an old individual. No value has been
estimated for the richly perfused tissues fraction of body-
weight because of a lack of information.
Table 1 summarizes physiological and metabolic data
used in the model in terms of changes between 25 and
65 years. All the values of the parameters that are chemical-
dependent can be found in detail in Truchon et al. (2003).
Exposure scenarios
Repeated occupational exposures were simulated at the cur-
rent threshold limit values (TLVs) (ACGIH® 2007): 8 h/
day, 5 days/week until steady state was reached in the tis-
sues. For the compounds having long half-lives, steady
state was also reached, by adding for example an initial
dose in the central compartment or by simulating the model
over long exposure times. Physical workload was set at
50 W during 12 h (including the 8 h of exposure) and at
0 W the remaining of the day.
Results
Modeling age diVerences in biological levels
The TK model was applied to 14 chemicals, representing
21 speciWc biological entities. These chemicals are exam-
ples among the list of BEIs (Truchon et al. 2003). For each
chemical, important physiological and metabolic parame-
ters were identiWed and included in the model structure
(Pierrehumbert et al. 2002). Results obtained while simulat-
ing the inXuence of age are summarized in Table 2 for the
ages of 25 and 65 years.
These preliminary simulations indicate in some cases
considerable diVerences due to age. Moreover, these diVer-
ences appear to depend on the chemical and the biological
entity considered. For some of them age does not seem to
aVect biological level; for others, TK calculations tend to
show that age is an important determinant.
Changes are of the order of 10–30% for almost half the
chemicals simulated by the TK model. About a quarter of
the substances shows diVerences less than 10% and for the
resting quarter variations are over 30%, with two examples
up to more than 50%.
Application to biological monitoring data
Predictions presented in Table 2 can be applied to biologi-
cal monitoring of exposure. Biological reference values
represent biological levels that would be observed in Xuids
collected in healthy workers repeatedly exposed at a given
reference air concentration. It can thus be expected that,
due to age, diVerent values would be observed. Table 3 pre-
sents levels that would be observed in 65-year-old workers,
taking young workers as reference. This information could
be used to improve our interpretation of biological monitor-
ing results, unless better information is available.
Discussion
The TK model used here is relatively simple and do not
represent each chemical’s speciWc detail. More elaborated
techniques, such as PBPK models, could give a better view
of the eVect of age. However, it would be more diYcult to
develop a general model for a category of chemicals
describing the diVerences due to age.
The present results indicate that the inXuence of age is
chemical-speciWc. Some chemicals seem to be hardly
aVected, while others show large diVerences. The same is
indeed true when considering biological indicators of expo-
sure.
For chemicals in blood, diVerences can be important due
for example to the presence of a peripheral compartment in123
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tion, the kidney fraction or the liver fraction of bodyweight
could explain an increase in the blood concentration of a
substance. When the peripheral compartment is represented
by the volume of body fat, diVerences are not so important.
Changes in body mass, or more speciWcally in total body
water and body fat, will have an inXuence on the distribu-
tion volumes of a chemical. The consequence can be an
increased concentration of hydrophilic substances and a
prolonged half-life for a lipophilic substance. Products with
a fast metabolism seem to have a little impact with age on
the blood concentration. In the case of the concentration in
the peripheral compartment, it seems to increase with age
when the target organ is represented by the liver or the kid-
neys. When looking at the diVerences due to age for the
metabolic and excretion compartment, it is evident that for
several chemicals the elimination parameters like the excre-
tion rate have a signiWcant impact on the concentrations. In
very few cases, there is a decrease in the urinary concentra-
tion of the substance when the aged person is compared to
the younger one, which could be explained by the interindi-
vidual variablity. Thus, it seems diYcult to set up simple
rules for a category of chemicals, each chemical being a
speciWc case, which has to be investigated on its own.
Parameters like metabolism, storage, long half-lives, hydro-
philic or lipophilic property of a chemical are often chemi-
cal-speciWc. It is not evident to do some classiWcation like
organic and inorganic products, or lipophilic and hydro-
philic substances because in both cases important and less
important diVerences exist.
In this context, TK models seem to be appropriate tools.
It is therefore essential to study and describe not only some
speciWc chemicals but also the mechanism underlying those
changes to be able to forecast changes for new chemicals.
When compared to global biological variability expected
in workers (Lin et al. 2005; Truchon et al. 2006), which is
about 30%, the tentative predictions made here indicate that
age could be in some cases an important determinant of
variability. The variability extent index estimated by Tru-
chon et al. (2006), which had not taken into account vari-
ability due to age, shows that, in some cases, the simulated
value of a 65-year-old worker can be out of the estimated
Table 2 Tentative predictions of age-related changes in biological levels of some occupational chemicals and their metabolites (age 65 compared
to age 25)
rpt richly perfused tissues
Biological indicator Relative change (%) 
in Ccentral comp.,blood
Age 65 years versus 
age 25 years
Peripheral 
compartment
Relative change (%) 
in Cperipheral comp.
Age 65 years versus 
age 25 years
Relative change (%) 
in Cmetabolite comp.,blood
Age 65 years versus 
age 25 years
Relative change (%) 
in Cexcretion,urine
Age 65 years versus 
age 25 years
Arsenic 1.0 ¡14.5
Methylarsonic acid 11.3 ¡24.0
Methylarsinic acid 63.7 53.0
Cadmium 32.4 Kidneys 17.9 10.5
Chromium (VI) 21.9 rpt 20.4 14.1
Cobalt 7.8 rpt 6.2 ¡11.6
2-Ethoxyethanol 6.2
2-Ethoxyacetic acid 38.3 34.8
Ethylbenzene 0.3 Fat 1.8
Mandelic acid 10.3
Fluorides 31.5 Skeleton 35.9 22.9
Lead 25.8 Skeleton 18.9
Manganese 27.2 Liver 48.2 7.0
Mercury 27.9 Kidneys 47.5 16.7
Methyl isobutyl ketone 19.8 Fat 17.7 44.0
Pentachlorophenol 33.5 7.3
Conjugated 
pentachlorophenol
10.7
Phenol 28.7 20.4
Toluene 3.2 Fat 5.1
Hippuric acid 29.8 13.6
o-Cresol 10.9123
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a Time of sampling: ES end of shift, EW end of workweek, ESW end of shift at end of workweek, NC not critical, PS prior to shift, PSW prior to
last shift of the workweek
b BEI biological exposure indices (ACGIH® 2007)
c VEI variability extent index with the 95% limit values (Truchon et al. 2006)
Chemical/biological 
indicator
Sampling 
timea
Corresponding 
exposure level
BEIb VEIc Simulated 
value 
Age 25 years
Simulated 
value
Age 65 years
Expected change (%) 
Age 65 years versus 
age 25 years
Arsenic 0.01 mg/m3
Inorganic arsenic 
and its metabolites 
in urine
EW 35 g As/l 14.2–66.9 63.7 84.2 32
Cadmium 0.01 mg/m3
Cadmium in urine NC 5 g/g 
creatinine
1.6–14.9 4.7 5.6 19
Cadmium in blood NC 5 g/l 3.8–6.5 1.2 1.7 42
Chromium (VI) 0.05 mg/m3
Chromium in urine ESW 25 g/l 15.4–72.3 43.9 51.9 18
Cobalt 0.02 mg/m3
Cobalt in urine ESW 15 g/l 4.7–17.9 10.4 9.8 ¡6
Cobalt in blood ESW 1 g/l 0.59–1.18 0.85 0.92 8
2-Ethoxyethanol 5 ppm
2-Ethoxyacetic 
acid in urine
ESW 100 mg/g 
creatinine
41.5–244.1 68.7 94.1 37
Ethylbenzene 100 ppm
Mandelic acid 
in urine
ESW 0.7 g/g 
creatinine
0.6–3.8 1.6 1.8 13
Fluorides 2.5 mg/m3
Fluorides in urine PS 3 mg/g 
creatinine
1.2–7.9 3.4 3.5 3
Fluorides in urine ES 10 mg/g 
creatinine
4.5–22.4 9.4 10.6 13
Lead 0.05 mg/m3
Lead in blood NC 300 g/l 161.2–561.6 188.5 217.6 15
Mercury (inorganic) 0.025 mg/m3
Mercury in urine PS 35 g/g 
creatinine
10.6–113.6 30.8 35.1 14
Mercury in blood ESW 15 g/l 9.2–25.1 13.6 16.7 23
Methylisobutylketone 50 ppm
Methylisobutylketone 
in urine
ES 2 mg/l 0.8–5 4.1 6.1 49
Pentachlorophenol 0.5 mg/m3
Conjugated 
pentachlorophenol 
in urine
PSW 2 mg/g 
creatinine
0.9–4.2 1.8 2.1 17
Pentachlorophenol 
in blood
ES 5 mg/l 2.7–10.1 3.7 4.7 27
Phenol 5 ppm
Phenol in urine ES 250 mg/g 
creatinine
97.4–511.4 327.9 402.1 23
Toluene 20 ppm
o-Cresol in urine ES 0.5 mg/l 0.16–1.53 0.98 1.09 11123
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several cases the simulated values exceed the biological
exposure indices. In very few cases, there is a decrease in
the urinary concentration of the substance when the aged
person is compared to the younger one. Predictions of age
diVerences in biological indicators were made based on
typical values for speciWc physiological and metabolic
parameters. Further work should be done to improve our
estimates of these parameters and in consequence their
inXuence. Notably, uncertainty and variability in these
parameters could be considered, using for example Monte–
Carlo simulations. Further studies, like human volunteer
exposure, need to be done to reach a better quantitative
description of age diVerences in biological monitoring
results.
Furthermore, the present predictions do not take into
account the apparition of various diseases with age and the
increase use of medications. These aspects would probably
enhance diVerences. The present predictions should there-
fore be considered as minima to be expected.
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